Product correctly added to cart.

discount label
BCR-ABL-IN-2
View 3D

Biosynth logo

BCR-ABL-IN-2

CAS: 897369-18-5

Ref. 3D-XKB36918

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Thursday 14 Nov 2024

Product Information

Name:
BCR-ABL-IN-2
Description:

BCR-ABL-IN-2 is a class of isoquinoline compounds that are substituted with phenylureas, pyrazoles, and dichlorobenzene. The substituents on the isoquinoline ring are arranged in such a way that they can be selectively cleaved by nitrosonium cations to form phenylurea derivatives. The phenylurea derivatives have been shown to inhibit the growth of cancer cells in vitro, but their effectiveness has yet to be determined in vivo.

The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is an antituberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
502.4 g/mol
Formula:
C24H25Cl2N5O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-XKB36918 BCR-ABL-IN-2

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".